NovoLog

Product NDC
50090-1665
11-digit product format
500901665
Labeler code
50090
Product ID
50090-1665_6c9f24f9-5a67-4bf8-8d5c-5ab2fbdbfd5a
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
insulin aspart
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS; SUBCUTANEOUS
Labeler
A-S Medication Solutions
Application
NDA020986
Marketing category
NDA
Marketing start
2001-08-27
Marketing end
0000-00-00
Substance
INSULIN ASPART
Active strength
100 [iU]/mL
Pharmacologic classes
Insulin [CS],Insulin Analog [EPC]
NDC exclude flag
No
Listing certified through
2019-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct50090-1665DDiscontinued by firm2026-08-11
excluded packagepackage50090-166550090-1665-0DDiscontinued by firm2026-08-11

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 24 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage50090-1665-0d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage50090-1665-0f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproduct2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage50090-1665-02ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproducta1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage50090-1665-0a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage50090-1665-0cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage50090-1665-0cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproduct302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage50090-1665-0302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproducted331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage50090-1665-0ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproduct0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage50090-1665-00efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08excluded productproductad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage50090-1665-0ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03excluded productproduct367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage50090-1665-0367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09excluded productproduct557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage50090-1665-0557ba5c1ecfa…9c80585c8c6e…

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
24eab60a-55c8-40c1-8c86-7ed01a7a8befProduct name120240227
09fb02dd-baf0-4f67-b464-599bf26324b6Product name220200323
6a6ef80c-37d6-4e02-aa78-fce7b811234eProduct name220200323
91ae268d-ee0f-6988-629d-5065a4376a50Product name220200323

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
50090-1665-0NOVOLOG3 mL in 1 CARTRIDGEINJECTION, SOLUTION328
50090-1665-0NOVOLOG5 in 1 CARTONINJECTION, SOLUTION528

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
50090-1665-0ML - Milliliter50090-16653ffae93a-e94d-4a68-9c2d-de5e638d50f612018-11-06

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
50090-1665NOVOLOG (INSULIN ASPART) INJECTION, SOLUTION [A-S MEDICATION SOLUTIONS]28Legacy NDC, 2 package rows20231210_e172b4f8-9b25-4019-8e09-afc10b2f30c9.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
NOVOLOGINSULIN ASPARTA-S Medication Solutionse172b4f8-9b25-4019-8e09-afc10b2f30c92023-12-09Warnings, Adverse reactionsExact identifier
ndc (product): 50090-1665

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1653196insulin aspart 100 UNT/ML in 3 ML CartridgePSNe172b4f8-9b25-4019-8e09-afc10b2f30c928
1653202insulin aspart 100 UNT/ML in 3 ML Pen InjectorPSNe172b4f8-9b25-4019-8e09-afc10b2f30c928
311040insulin aspart 100 UNT/ML Injectable SolutionPSNe172b4f8-9b25-4019-8e09-afc10b2f30c928
1653198NovoLOG 100 UNT/ML in 3 ML CartridgePSNe172b4f8-9b25-4019-8e09-afc10b2f30c928
1653204NovoLOG 100 UNT/ML in 3 ML Pen InjectorPSNe172b4f8-9b25-4019-8e09-afc10b2f30c928
351926NovoLOG 100 UNT/ML Injectable SolutionPSNe172b4f8-9b25-4019-8e09-afc10b2f30c928
16531983 ML insulin aspart, human 100 UNT/ML Cartridge [NovoLog]SBDe172b4f8-9b25-4019-8e09-afc10b2f30c928
16532043 ML insulin aspart, human 100 UNT/ML Pen Injector [NovoLog]SBDe172b4f8-9b25-4019-8e09-afc10b2f30c928
351926insulin aspart, human 100 UNT/ML Injectable Solution [NovoLog]SBDe172b4f8-9b25-4019-8e09-afc10b2f30c928
16531963 ML insulin aspart, human 100 UNT/ML CartridgeSCDe172b4f8-9b25-4019-8e09-afc10b2f30c928
16532023 ML insulin aspart, human 100 UNT/ML Pen InjectorSCDe172b4f8-9b25-4019-8e09-afc10b2f30c928
311040insulin aspart, human 100 UNT/ML Injectable SolutionSCDe172b4f8-9b25-4019-8e09-afc10b2f30c928
16531983 ML NovoLog 100 UNT/ML CartridgeSYe172b4f8-9b25-4019-8e09-afc10b2f30c928
16532043 ML NovoLog 100 UNT/ML Pen InjectorSYe172b4f8-9b25-4019-8e09-afc10b2f30c928
311040insulin analog, aspart 100 UNT/ML Injectable SolutionSYe172b4f8-9b25-4019-8e09-afc10b2f30c928
1653196insulin, aspart, human 100 UNT/ML per 3 ML CartridgeSYe172b4f8-9b25-4019-8e09-afc10b2f30c928
1653202insulin, aspart, human 100 UNT/ML per 3 ML Pen InjectorSYe172b4f8-9b25-4019-8e09-afc10b2f30c928
351926NovoLog 100 UNT/ML Injectable SolutionSYe172b4f8-9b25-4019-8e09-afc10b2f30c928
1653204NovoLog FlexPen 100 UNT/ML per 3 ML Pen InjectorSYe172b4f8-9b25-4019-8e09-afc10b2f30c928
1653204NovoLog FlexTouch 100 UNT/ML per 3 ML Pen InjectorSYe172b4f8-9b25-4019-8e09-afc10b2f30c928

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsStatus
50090-1665-0500901665003 mL in 1 CARTRIDGE3 mlHistorical